VBCR - June 2017, Vol 6, No 2

Patients from the Corrona registry, an independent, observational US registry housing data on patients with rheumatic diseases, were included in Dr Harrold and colleagues’ study if they had received a PsA diagnosis; had initiated therapy with a TNFi (ie, adalimumab, etanercept, golimumab, or infliximab) between October 1, 2002, and March 21, 2013; and were aged ≥18 years.

Advances in contemporary imaging techniques have led to more widespread use of this modality for the management of osteoarthritis (OA). However, in the absence of evidence-based guidelines, imaging is often used in circumstances where it does not change management.

Using the 2014 EULAR standardized operating procedures, a task force designated by ASAS-EULAR that included 39 members who represented 14 nations in Europe, North America, and South America reviewed the results of 2 systematic literature reviews, carried out by 2 fellows to gather evidence published since 2009 that pertained to all treatment options.
The FDA expanded its approval of subcutaneous tocilizumab (Actemra) for the treatment of adult patients with giant-cell arteritis, a chronic and severe autoimmune condition.
Researchers have developed and validated a new algorithm to use with electronic health records (EHRs) that can accurately identify patients with systemic lupus erythematosus (SLE; Barnado A, et al. Arthritis Care Res [Hoboken]. 2017;69:687-693).
Our findings provide evidence for a potential cardiovascular protective effect of allopurinol in patients with gout and diabetes, a group of patients at high risk for cardiovascular events, the researchers concluded.

To reduce gout flares, colchicine or a nonsteroidal anti-inflammatory drug was given 14 days before baseline through month 5, unless patients could not tolerate these prophylactic drugs.
Based on the results of their study, Dr Grainger and colleagues asserted that current mobile applications available to assist in the management of patients with RA are configured as simple calculators for rheumatologists or as data tracking tools for patients, and the latter do not uniformly collect data using validated instruments.
Page 1 of 2
Results 1 - 10 of 17
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology